Fundraising Fox

Intensity Therapeutics

NASDAQ: INTS

Shelton, US · Founded 2012 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

Intensity Therapeutics was founded in 2012 by Lewis H. Bender and Ian B. Walters, M.D..

LH
Lewis H. BenderCo-founder
IB
Ian B. Walters, M.D.Co-founder
JT
Joseph TalamoExecutive
RC
Robert CookeExecutive

Board

TI
Thomas I.H. DubinBoard director
MA
Mark A. GoldbergBoard director
EL
Emer LeahyBoard director
DD
Daniel DonovanBoard director

Investors · 1

VCapitalreportedChicago

Reported raises · per SEC filings

Form D private placements

$5.9M disclosed across 3 rounds · 2013–2024

▶$3.6MraisedDec 2024 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas I.H. DubinDirector
  • Mark A. GoldbergDirector
  • Joseph TalamoExecutive Officer
  • Emer LeahyDirector
  • Lewis H. BenderExecutive Officer, Director
  • Daniel DonovanDirector
Offering amount
$3.6M
Amount sold
$3.6M
Sales commissions
$120K
Finders' fees
$100K
Placement agents
Brookline Capital Markets, a division of Arcadia Securities, LLC, A.G.P./Alliance Global Partners
First sale
Nov 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$500KraisedJun 2015 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Lewis H. BenderExecutive Officer, Director
  • Ian B. Walters, M.D.Executive Officer
Offering amount
$5M
Amount sold
$500K
First sale
May 2015
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.8MraisedDec 2014 · 20 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert CookeExecutive Officer
  • Lewis H. BenderExecutive Officer, Director
  • Ian B. Walters, M.D.Executive Officer
Amount sold
$1.8M
Sales commissions
$40K
Placement agents
Cato Capital, LLC
First sale
Jan 2013
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Shelton biotech prepares to restart late-stage cancer trial after funding pausehartfordbusiness.com · Aug 2026Earnings call transcript: Intensity Therapeutics misses Q2 2026 EPS as shares slip premarket By Investing.cominvesting.com · Aug 2026Intensity Therapeutics to Announce Second Quarter 2026 Financial Results on August 11, 2026 | Morningstarmorningstar.com · Aug 2026Intensity Therapeutics Provides Mid-Year Update Highlighting Late-Stage Development Programs and Strategic Partnering Opportunities for INT230-6prnewswire.com · Jul 2026Intensity Therapeutics, Inc. Raises $6.6 Million from At The Market Offering (ATM) Stock Sales in July 2025prnewswire.com · Aug 2025Intensity Therapeutics, Inc. Raises $10 Million to Fund Clinical Supplies Manufacturing and Phase I/II Trials of INT230-6 - Intensity Therapeuticsintensitytherapeutics.com · Jun 2016

Frequently asked questions

Who founded Intensity Therapeutics?
Intensity Therapeutics was founded by Lewis H. Bender, Ian B. Walters, M.D. in 2012.
Who are Intensity Therapeutics's investors?
Intensity Therapeutics's investors include VCapital.
How much funding has Intensity Therapeutics raised?
Intensity Therapeutics has disclosed $5.9M raised across 3 rounds.
Where is Intensity Therapeutics headquartered?
Intensity Therapeutics is headquartered in Shelton, US.